Towards a genome-wide CRISPR/Cas9 mutant library in Rhizopus delemar
德莱马根霉 (Rhizopus delemar) 中的全基因组 CRISPR/Cas9 突变体文库
基本信息
- 批准号:10573271
- 负责人:
- 金额:$ 18.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Amphotericin BCRISPR/Cas technologyClinicalCodeCollectionConsumptionDNA Polymerase IIIDNA sequencingDideoxy Chain Termination DNA SequencingFungal Drug ResistanceFutureGene MutationGenerationsGenesGeneticGenomeGenotypeGlycine-Specific tRNAGrowthGuide RNAHealthHumanImmunologic Deficiency SyndromesInduced MutationLibrariesLifeLigationMolecularMolecular DiseaseMorphologyMucormycosisMutagenesisMutationNutritional RequirementsPathogenesisPatientsPhenotypePoint MutationProteinsRNARandom AllocationResearchResearch Project GrantsResistanceResourcesRhizopusSequence HomologySpecificitySystemTimeVirulencedesignefficacy evaluationexpression vectorgene gungenome-wideimprovedinnovationmortalitymutantnext generation sequencingoff-target mutationpathogenic funguspromotersuccesstoolvectorwhole genome
项目摘要
Rhizopus delemar is the primary cause of life-threatening mucormycosis
responsible for
approximately 70% of clinical cases, with an overall mortality rate exceeding 50%. Despite its
devastating impact on human health,
much of R. delemar’s pathobiology and molecular disease
mechanisms remains unknown. As an initial step towards constructing a high-throughput genome-wide
mutant library of R. delemar, we propose
to generate a small-scale targeted mutant library utilizing
multiplex CRISPR/Cas9 technology. In Specific Aim 1, we will synthesize a collection of single-guide
RNAs (sgRNAs) targeting 40 randomly selected genes and deliver pooled sgRNAs and Cas9 in a one-
vector construct into R. delemar. In Specific Aim 2, we will identify gene mutations using Sanger DNA
sequencing and high-throughput next-generation sequencing. We will also assess efficacy, specificity,
and off-target mutations induced by multiplex CRISPR/Cas9. The success of this exploratory research
effort will lead to the construction of whole-genome CRISPR/Cas9 mutant libraries for the systemic
examination of R. delemar pathogenesis mechanisms.
德莱马根霉是危及生命的毛霉菌病的主要原因
负责
约占临床病例的70%,总死亡率超过50%。尽管其
对人类健康造成毁灭性影响,
R. delemar 的大部分病理学和分子疾病
机制仍不清楚。作为构建高通量全基因组的第一步
R. delemar 突变体文库,我们建议
利用生成小规模靶向突变体库
多重 CRISPR/Cas9 技术。在具体目标 1 中,我们将综合一系列单一指南
RNA (sgRNA) 以 40 个随机选择的基因为目标,并以单次方式提供汇集的 sgRNA 和 Cas9
将载体构建到 R. delemar 中。在具体目标 2 中,我们将使用 Sanger DNA 识别基因突变
测序和高通量下一代测序。我们还将评估功效、特异性、
以及多重 CRISPR/Cas9 诱导的脱靶突变。这项探索性研究的成功
努力将导致构建全基因组 CRISPR/Cas9 突变体文库,用于系统性研究
检查 R. delemar 发病机制。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Methionine biosynthesis enzyme MoMet2 is required for rice blast fungus pathogenicity by promoting virulence gene expression via reducing 5mC modification.
- DOI:10.1371/journal.pgen.1010927
- 发表时间:2023-09
- 期刊:
- 影响因子:4.5
- 作者:
- 通讯作者:
Cryptococcal Hsf3 controls intramitochondrial ROS homeostasis by regulating the respiratory process.
隐球菌 Hsf3 通过调节呼吸过程来控制线粒体内 ROS 稳态
- DOI:10.1038/s41467-022-33168-1
- 发表时间:2022-09-15
- 期刊:
- 影响因子:16.6
- 作者:
- 通讯作者:
Interplay between acetylation and ubiquitination of imitation switch chromatin remodeler Isw1 confers multidrug resistance in Cryptococcus neoformans.
- DOI:10.7554/elife.85728
- 发表时间:2024-01-22
- 期刊:
- 影响因子:7.7
- 作者:Meng Y;Ni Y;Li Z;Jiang T;Sun T;Li Y;Gao X;Li H;Suo C;Li C;Yang S;Lan T;Liao G;Liu T;Wang P;Ding C
- 通讯作者:Ding C
Homeostasis of cell wall integrity pathway phosphorylation is required for the growth and pathogenicity of Magnaporthe oryzae.
- DOI:10.1111/mpp.13225
- 发表时间:2022-08
- 期刊:
- 影响因子:4.9
- 作者:Cai Y;Liu X;Shen L;Wang N;He Y;Zhang H;Wang P;Zhang Z
- 通讯作者:Zhang Z
MoErv14 mediates the intracellular transport of cell membrane receptors to govern the appressorial formation and pathogenicity of Magnaporthe oryzae.
- DOI:10.1371/journal.ppat.1011251
- 发表时间:2023-04
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PING WANG其他文献
PING WANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PING WANG', 18)}}的其他基金
Towards a genome-wide CRISPR/Cas9 mutant library in Rhizopus delemar
德莱马根霉 (Rhizopus delemar) 中的全基因组 CRISPR/Cas9 突变体文库
- 批准号:
10431481 - 财政年份:2022
- 资助金额:
$ 18.38万 - 项目类别:
Isolation of mononuclear propagules from coenocytic hyphae of the mucormycosis pathogen Rhizopus delemar
从毛霉菌病病原体德莱马根霉的共生菌丝中分离单核繁殖体
- 批准号:
10353429 - 财政年份:2021
- 资助金额:
$ 18.38万 - 项目类别:
Isolation of mononuclear propagules from coenocytic hyphae of the mucormycosis pathogen Rhizopus delemar
从毛霉菌病病原体德莱马根霉的共生菌丝中分离单核繁殖体
- 批准号:
10221180 - 财政年份:2021
- 资助金额:
$ 18.38万 - 项目类别:
RADX TECH PROJECT - WORK PACKAGE 1 SUPPORT
RADX 技术项目 - 工作包 1 支持
- 批准号:
10505995 - 财政年份:2021
- 资助金额:
$ 18.38万 - 项目类别:
Mechanisms of Radiation-induced Vascular Endothelial Cell Injury and Its Correction
辐射引起的血管内皮细胞损伤的机制及其纠正
- 批准号:
9391119 - 财政年份:2017
- 资助金额:
$ 18.38万 - 项目类别:
Genome editing in Rhizopus delemar using using CRISPR-Cas systems
使用 CRISPR-Cas 系统对德勒马根霉进行基因组编辑
- 批准号:
9179413 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Novel Approaches to Maintaining Organ Function in Sepsis
维持脓毒症器官功能的新方法
- 批准号:
10153818 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Novel Approaches to Maintaining Organ Function in Sepsis
维持脓毒症器官功能的新方法
- 批准号:
10405950 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Genome editing in Rhizopus delemar using using CRISPR-Cas systems
使用 CRISPR-Cas 系统对德勒马根霉进行基因组编辑
- 批准号:
9304959 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
Novel Approaches to Maintaining Organ Function in Sepsis
维持脓毒症器官功能的新方法
- 批准号:
9698963 - 财政年份:2016
- 资助金额:
$ 18.38万 - 项目类别:
相似海外基金
Integrating CRISPR-Cas Technology into Organic Electronics for Rapid Point-of-Care Genotyping
将 CRISPR-Cas 技术集成到有机电子器件中以实现快速护理点基因分型
- 批准号:
BB/X003442/1 - 财政年份:2023
- 资助金额:
$ 18.38万 - 项目类别:
Research Grant
Platform for CRISPR/Cas technology and AAV atherosclerosis model (S03)
CRISPR/Cas技术和AAV动脉粥样硬化模型平台(S03)
- 批准号:
408096640 - 财政年份:2018
- 资助金额:
$ 18.38万 - 项目类别:
Collaborative Research Centres














{{item.name}}会员




